The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro. (Q52787532)
Jump to navigation
Jump to search
scientific article published on 23 February 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro. |
scientific article published on 23 February 2017 |
Statements
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro. (English)
1 reference
Elke Tatjana Aristizabal Prada
1 reference
Svenja Nölting
1 reference
Gerald Spoettl
1 reference
Julian Maurer
1 reference
Christoph Joseph Auernhammer
1 reference
23 February 2017
1 reference